524715 Valuation

SP
Do you wonder what the value of SUN PHARMACEUTICAL is? SUN PHARMACEUTICAL current Real Value cannot be determined due to lack of data. The regular price of SUN PHARMACEUTICAL is 0.0. Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Our model measures the value of SUN PHARMACEUTICAL from evaluating the company fundamentals such as price to earning of 50.37 X as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we recommend taking in undervalued stocks and trading overvalued stocks since, at some point in time, asset prices and their ongoing real values will draw towards each other.

Search Valuation

 
Refresh
SUN PHARMACEUTICAL Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as SUN PHARMACEUTICAL's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

SUN PHARMACEUTICAL Total Value Analysis

SUN PHARMACEUTICAL INDUSTRIES is presently forecasted to have takeover price of 1060 B with market capitalization of 1060 B, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the SUN PHARMACEUTICAL fundamentals before making investing decisions based on enterprise value of the company

SUN PHARMACEUTICAL Asset Utilization

Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Check out Trending Equities. Please also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page